| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 20.85▼ | 20.83▼ | 20.82▼ | 20.80▼ | 20.87▼ |
| MA10 | 20.83▼ | 20.81▼ | 20.80▼ | 20.78▼ | 20.87▼ |
| MA20 | 20.79▼ | 20.79▼ | 20.78▼ | 20.88▼ | 20.69▲ |
| MA50 | 20.86▼ | 20.89▼ | 20.90▼ | 20.89▼ | N/A |
| MA100 | 20.90▼ | 20.88▼ | 20.89▼ | 20.67▲ | N/A |
| MA200 | 20.89▼ | 20.77▼ | 20.70▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.012▲ | 0.011▲ | -0.017▼ | N/A |
| RSI | 40.650▼ | 41.123▼ | 41.417▼ | 40.317▼ | 58.368▲ |
| STOCH | 75.833 | 73.646 | 77.292 | 38.971 | 53.545 |
| WILL %R | -81.250▼ | -81.250▼ | -81.250▼ | -100.000▼ | -56.410 |
| CCI | -79.032 | -57.215 | -71.441 | -77.959 | -9.969 |
| ▼ MA | $BSCZ MA(20) Crossed Below MA(50) | Set Alert |
|
Monday, October 20, 2025 11:25 PM
NovaBay Pharmaceuticals (NYSE:NBY) has formally regained compliance with the NYSE American's continued listing standards, successfully resolving deficiencies first cited in April and May 2024. The ...
|
|
Wednesday, October 15, 2025 07:17 AM
Biotechnology company bioAffinity Technologies (NASDAQ:BIAF) said on Wednesday that it has regained compliance with Nasdaq's all applicable continued listing requirements. In a letter dated October 14 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 20.78 | 20.8242 | 20.72 | 20.72 | 38,045 |
| 13/11/25 | 20.80 | 20.81 | 20.75 | 20.75 | 95,254 |
| 12/11/25 | 20.86 | 20.86 | 20.84 | 20.855 | 21,399 |
| 11/11/25 | 20.83 | 20.89 | 20.829 | 20.885 | 987,669 |
| 10/11/25 | 20.80 | 20.81 | 20.77 | 20.795 | 18,883 |
| 07/11/25 | 20.78 | 20.81 | 20.7733 | 20.78 | 12,756 |
| 06/11/25 | 20.804 | 20.829 | 20.7903 | 20.82 | 19,788 |
| 05/11/25 | 20.78 | 20.78 | 20.72 | 20.7243 | 53,133 |
| 04/11/25 | 20.77 | 20.84 | 20.76 | 20.775 | 46,133 |
| 03/11/25 | 20.746 | 20.75 | 20.73 | 20.745 | 40,700 |
|
|
||||
|
|
||||
|
|